- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07950982
STIL Block Versus Paravertebral Block for Pain Relief After Modified Radical Mastectomy (STIL-PVB-MRM)
Ultrasound-Guided Subtransverse Interligamentary (STIL) Block Versus Paravertebral Block (PVB) for Postoperative Analgesia in Modified Radical Mastectomy: A Randomized Controlled Trial
Breast cancer surgery, particularly modified radical mastectomy (MRM), can cause significant postoperative pain. Effective pain management is important to improve patient comfort, facilitate recovery, reduce opioid consumption, and potentially decrease the risk of persistent post-mastectomy pain.
This randomized controlled clinical trial aims to compare the effectiveness of ultrasound-guided subtransverse interligamentary (STIL) block and thoracic paravertebral block (PVB) for postoperative pain relief in female patients undergoing modified radical mastectomy.
Eligible patients will be randomly allocated into three groups: the STIL block group, the PVB group, and a control group receiving general anesthesia without a regional block. Both regional blocks will be performed under ultrasound guidance at the T4 thoracic level using 25 mL of 0.25% bupivacaine combined with 4 mg dexamethasone.
Postoperative pain will be assessed using a visual analogue scale (VAS) at rest and during movement. The study will also evaluate postoperative morphine consumption, time to first rescue analgesia, intraoperative fentanyl requirements, recovery characteristics, patient satisfaction, postoperative nausea and vomiting, and block-related complications.
The primary objective is to compare postoperative pain scores at rest 24 hours after surgery between patients receiving STIL block and those receiving PVB.
The findings may help determine whether STIL block provides an effective alternative to thoracic paravertebral block for postoperative analgesia following modified radical mastectomy.
Обзор исследования
Статус
Условия
Подробное описание
BACKGROUND AND RATIONALE:
Modified radical mastectomy (MRM) is a commonly performed surgical procedure for the management of breast cancer. Postoperative pain remains an important concern and may interfere with respiratory function, delay mobilization, prolong hospital stay, and negatively affect patient recovery and satisfaction.
Thoracic paravertebral block (PVB) is an established regional anesthesia technique for breast surgery that provides effective postoperative analgesia and reduces opioid requirements. However, it requires considerable technical expertise and carries potential complications, including pleural puncture, pneumothorax, vascular injury, and inadvertent neuraxial spread of local anesthetic.
The ultrasound-guided subtransverse interligamentary (STIL) block is a relatively novel paraspinal regional anesthesia technique. Local anesthetic is injected into the space between the transverse process and the intertransverse ligament, allowing spread toward the thoracic paravertebral space.
This study aims to compare the postoperative analgesic efficacy of STIL block with thoracic PVB in patients undergoing MRM.
STUDY DESIGN AND POPULATION:
This is a prospective, randomized, controlled clinical trial involving 60 female patients with breast cancer scheduled for modified radical mastectomy at the National Cancer Institute, Cairo University.
Eligible patients will be aged 18-65 years, have an ASA physical status of II-III, and a body mass index between 20 and 35 kg/m².
Patients will be randomly allocated into three equal groups, with 20 patients in each group:
Group I - STIL Block:
Patients will receive ultrasound-guided subtransverse interligamentary block at the T4 thoracic level before induction of general anesthesia.
Group II - Paravertebral Block:
Patients will receive ultrasound-guided thoracic paravertebral block at the T4 thoracic level before induction of general anesthesia.
Group III - Control:
Patients will receive general anesthesia without any regional nerve block.
INTERVENTION DETAILS:
Both regional anesthesia techniques will be performed approximately 30 minutes before induction of general anesthesia.
In the STIL group, a 22-gauge echogenic spinal needle will be advanced under ultrasound guidance into the subtransverse interligamentary space at T4. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally.
In the PVB group, a 22-gauge echogenic spinal needle will be advanced under ultrasound guidance into the thoracic paravertebral space at T4. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally.
All patients will receive standardized general anesthesia and multimodal postoperative analgesia according to the study protocol.
GENERAL ANESTHESIA AND POSTOPERATIVE ANALGESIA:
General anesthesia will be induced using intravenous propofol, fentanyl, and rocuronium and maintained with sevoflurane in oxygen-enriched air.
All patients will receive intravenous paracetamol 1 g and ketorolac 30 mg as part of the multimodal analgesic regimen, subject to suitability.
Postoperative analgesia will include intravenous paracetamol 1 g and ketorolac 30 mg every 8 hours. Rescue analgesia will be provided using intravenous morphine 3 mg increments whenever the visual analogue scale (VAS) pain score is ≥4.
OUTCOME ASSESSMENT:
Primary Outcome:
The primary outcome is the postoperative pain score at rest, assessed using the visual analogue scale (VAS) 24 hours after surgery, comparing the STIL and PVB groups.
Secondary Outcomes:
- Postoperative pain scores at rest and during movement at predefined time points.
- Total postoperative morphine consumption during the first 24 hours.
- Time to first rescue analgesic request.
- Total intraoperative fentanyl consumption.
- Hemodynamic parameters, including heart rate and mean arterial pressure.
- Dermatomal sensory distribution and block failure rate.
- Block performance time, number of needle passes, and number of attempts.
- Postoperative nausea and vomiting.
- Patient satisfaction with postoperative analgesia.
- Recovery characteristics.
- Block-related complications and adverse events.
BLINDING AND RANDOMIZATION:
Patients will be randomly allocated using a computer-generated randomization sequence and sequentially numbered opaque sealed envelopes.
The study will be double-blinded. Patients and postoperative outcome assessors will be unaware of group allocation. Regional blocks will be performed by an anesthesiologist who will not participate in postoperative data collection. Identical adhesive dressings will be applied to the thoracic area in all patients.
STATISTICAL ANALYSIS:
Data will be analyzed using IBM SPSS Statistics version 27. Appropriate parametric and nonparametric statistical tests will be used according to data distribution. A p-value ≤0.05 will be considered statistically significant.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Armia M shafeek, MD
- Номер телефона: 01200456797
- Электронная почта: Armia.shafeek@nci.cu.edu.eg
Места учебы
-
-
-
Cairo, Египет, 11796
- Рекрутинг
- National Cancer Institute, Cairo University
-
Контакт:
- Armia M shafeek, MD
- Номер телефона: +201200456797
- Электронная почта: Armia.shafeek@nci.cu.edu.eg
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
**Inclusion Criteria:**
- Female patients scheduled for modified radical mastectomy for breast cancer.
- American Society of Anesthesiologists (ASA) physical status II-III.
- Age between 18 and 65 years.
- Body mass index (BMI) between 20 and 35 kg/m².
**Exclusion Criteria:**
- Patient refusal to participate.
- ASA physical status IV or higher.
- Age below 18 or above 65 years.
- BMI below 20 or above 35 kg/m².
- Known allergy to local anesthetics, opioids, or any of the study medications.
- History of chronic pain or psychiatric illness.
- Contraindications to regional anesthesia, including local infection at the injection site, coagulopathy, or pre-existing neuropathy.
- Severe cardiac, hepatic, renal, or respiratory disease.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: STIL Block Group
Patients will receive ultrasound-guided Subtransverse Interligamentary (STIL) block at the T4 thoracic level, performed approximately 30 minutes before induction of general anesthesia. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally. |
Ultrasound-guided Subtransverse Interligamentary (STIL) block performed at the T4 thoracic level approximately 30 minutes before induction of general anesthesia. A 22-gauge echogenic spinal needle will be advanced in-plane beneath the intertransverse ligament into the subtransverse interligamentary space. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally. |
|
Активный компаратор: Paravertebral Block Group
Patients will receive ultrasound-guided thoracic Paravertebral Block (PVB) at the T4 thoracic level, performed approximately 30 minutes before induction of general anesthesia. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally. |
Ultrasound-guided thoracic paravertebral block performed at the T4 thoracic level approximately 30 minutes before induction of general anesthesia. A 22-gauge echogenic spinal needle will be advanced in-plane toward the thoracic paravertebral space. Following negative aspiration, 25 mL of 0.25% bupivacaine combined with dexamethasone 4 mg will be injected incrementally. |
|
Без вмешательства: Control Group
Patients will receive general anesthesia without any regional anesthesia block. Intraoperative and postoperative analgesia will be provided according to the standardized multimodal analgesic protocol, including intravenous paracetamol and ketorolac, with intravenous morphine as rescue analgesia when the VAS pain score is ≥4. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Postoperative Pain Score at Rest at 24 Hours
Временное ограничение: 24 hours after surgery
|
Postoperative pain intensity at rest will be assessed using the Visual Analogue Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), 24 hours after surgery. The primary comparison will be between the STIL block and paravertebral block groups. |
24 hours after surgery
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Postoperative Pain Scores at Rest and During Movement
Временное ограничение: PACU, 1, 2, 4, 6, 12, and 18 hours after surgery
|
Pain intensity will be assessed using the Visual Analogue Scale (VAS), ranging from 0 to 10, both at rest and during movement. |
PACU, 1, 2, 4, 6, 12, and 18 hours after surgery
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Armia M shafeek, MD, National Cancer Institute, Cairo
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
- Боль
- Неврологические проявления
- Послеоперационные осложнения
- Патологические процессы
- Новообразования по локализации
- Новообразования
- Кожные заболевания
- Заболевания груди
- Патологические состояния, признаки и симптомы
- Заболевания кожи и соединительной ткани
- Признаки и симптомы
- Боль, Послеоперационный
- Новообразования молочной железы
- Пищеварительная система и физиологические явления полости рта
- Стоматология
- Стоматологические физиологические явления
- Зубная окклюзия
Другие идентификационные номера исследования
- AP2611-201-253-215
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Individual participant data will not be shared with other researchers because no data-sharing plan has been established for this study. Study results will be disseminated through scientific publications, while participant confidentiality and data privacy will be maintained in accordance with institutional ethical requirements.
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .